10-K: ProKidney Corp. Details Registered Securities in 10-K Filing

ProKidney Corp.'s 10-K filing details the terms of its Class A and Class B ordinary shares, as well as preference shares, and includes information on voting rights, dividend rights, transfer of shares, and liquidation procedures.

Summary

• ProKidney Corp., a Cayman Islands exempted company, has registered Class A ordinary shares and also has Class B ordinary shares that are exchangeable for Class A shares.
• The company is authorized to issue 500 million Class A shares, 500 million Class B shares, and 5 million preference shares, all with a par value of $0.0001 per share.
• Holders of both Class A and Class B shares have one vote per share and vote together as a single class on all matters, with no cumulative voting for directors.
• The board of directors can issue preference shares without shareholder approval, potentially impacting dividend rights, voting power, liquidation rights, and control of the company.
• As of December 31, 2023, there were no preference shares outstanding, and the company has no current plans to issue any.
• Class A shareholders may receive cash dividends at the discretion of the board, while Class B shareholders do not participate in dividends.
• Share rights can be varied with a three-fourths consent of the affected class, unless the directors deem the variation not adverse.
• Class A shareholders do not have preemptive or conversion rights, while Class B shareholders have no preemptive, subscription, redemption, or conversion rights.
• Share transfers are subject to Nasdaq, SEC, and other regulatory rules, and the board may decline transfers of unpaid shares or those with liens or restrictions.
• In the event of liquidation, Class A shareholders receive remaining assets proportionally, while Class B shareholders receive an amount equal to their paid-up capital.
• The company has indemnification agreements with directors and officers, but the SEC believes indemnification for Securities Act liabilities is against public policy.
• The company's articles of association include anti-takeover provisions, such as a classified board and the ability to issue preference shares, which could deter or prevent a change of control.
• The company's board is divided into three classes with staggered three-year terms, making it more difficult for shareholders to change the board's composition.
• Shareholders may approve corporate matters by unanimous written consent without a meeting.
• The company's articles can be amended by ordinary or special resolution, and shareholders are limited in their ability to call special meetings or put proposals before a general meeting.
• The company does not provide for cumulative voting, and transactions with interested members must be in the best interests of the company.
• The company may be wound up by court order or by a special resolution of its members.
• There are no limitations on the rights of non-resident or foreign members to hold or exercise voting rights.
• The board can issue shares or options without member approval, and shareholders do not have a general right to inspect company records.
• The articles of association waive the obligation of independent directors to provide business opportunities to the company, except for opportunities presented in their capacity as directors.
• The company is not obliged to call annual general meetings, but Nasdaq requires an annual meeting.
• The transfer agent and registrar for the ordinary shares is Continental Stock Transfer & Trust Company.
• The Class A shares are listed on the Nasdaq Capital Market under the symbol PROK.
• Cayman Islands courts may not enforce judgments from U.S. courts based on U.S. securities laws.
• The company must comply with anti-money laundering and data protection laws in the Cayman Islands.
• The company collects and uses personal data for lawful purposes, including compliance with legal obligations and legitimate business interests.

Sentiment

Score: 6

Explanation: The document is neutral in tone, providing factual information about the company's registered securities. There are some potential risks mentioned, but overall, the document is not overly positive or negative.

Positives

• The company has a clear structure for its share capital, including Class A, Class B, and preference shares.
• The board of directors has the flexibility to issue preference shares to raise capital or for other corporate purposes.
• The company has established procedures for share transfers, subject to regulatory rules.
• The company has indemnification agreements with directors and officers.
• The company is listed on the Nasdaq Capital Market, providing liquidity for its Class A shares.
• The company has implemented anti-money laundering and data protection procedures.

Negatives

• Class B shareholders do not participate in dividends.
• The board's ability to issue preference shares without shareholder approval could dilute the voting power of ordinary shareholders.
• The company's articles of association include anti-takeover provisions that could deter or prevent a change of control.
• Shareholders have limited ability to call special meetings or put proposals before a general meeting.
• Cayman Islands courts may not enforce judgments from U.S. courts based on U.S. securities laws.
• Shareholders do not have a general right to inspect company records.

Risks

• The issuance of preference shares could restrict dividends for ordinary shareholders and dilute their voting power.
• Anti-takeover provisions in the articles of association could deter or prevent a change of control.
• The lack of cumulative voting could limit minority shareholder representation on the board.
• The company's reliance on Cayman Islands law may make it difficult for shareholders to protect their interests.
• The company's indemnification agreements with directors and officers may be unenforceable under U.S. securities laws.
• The company's compliance with anti-money laundering and data protection laws may be costly and time-consuming.

Future Outlook

The company has no present plans to designate the rights of or to issue any preference shares.

Industry Context

This document is a standard description of registered securities, which is a common requirement for publicly traded companies. The details provided are specific to ProKidney Corp. and its unique share structure.

Comparison to Industry Standards

• The share structure of ProKidney Corp., with both Class A and Class B ordinary shares, is not uncommon, but the specific rights and restrictions associated with each class are unique to the company.
• The anti-takeover provisions, such as a classified board and the ability to issue preference shares, are common in corporate governance documents to protect the company from hostile takeovers.
• The indemnification agreements with directors and officers are standard practice for publicly traded companies to attract and retain qualified individuals.
• The company's compliance with anti-money laundering and data protection laws is consistent with global regulatory requirements for financial institutions and companies handling personal data.

Stakeholder Impact

• Shareholders should be aware of the voting rights and dividend rights associated with each class of shares.
• Potential investors should consider the anti-takeover provisions and the board's ability to issue preference shares.
• Directors and officers should be aware of the indemnification agreements and their limitations.
• The company's compliance with anti-money laundering and data protection laws may impact stakeholders who provide personal data.

Keywords

Class A ordinary shares, Class B ordinary shares, preference shares, voting rights, dividend rights, share transfer, liquidation, anti-takeover provisions, Cayman Islands law, indemnification, corporate governance, data protection, anti-money laundering